(Q34017518)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19441869%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

review article

1 reference

title

Ceftaroline: a novel broad-spectrum cephalosporin with activity against meticillin-resistant Staphylococcus aureus (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19441869%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

main subject

Staphylococcus aureus

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19441869%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Philippe Lagacé-Wiens

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19441869%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

1

George G Zhanel

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19441869%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

9

James A Karlowsky

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19441869%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

author name string

Grace Sniezek

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19441869%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Frank Schweizer

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19441869%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Ethan Rubinstein

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19441869%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Alfred S Gin

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19441869%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Daryl J Hoban

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19441869%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

publication date

1 January 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19441869%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19441869%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

volume

69

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19441869%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19441869%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

page(s)

809-831

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19441869%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.2165/00003495-200969070-00003

28 January 2020

exact match

0 references

cites work

Stability and stabilization studies of TAK-599 (Ceftaroline Fosamil), a novel N-phosphono type prodrug of anti-methicillin resistant Staphylococcus aureus cephalosporin T-91825.

1 reference

12 December 2020

Linezolid: effectiveness and safety for approved and off-label indications

1 reference

12 December 2020

TAK-599, a novel N-Phosphono type prodrug of anti-MRSA cephalosporin T-91825: synthesis, physicochemical and pharmacological properties

1 reference

12 December 2020

In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.

1 reference

12 December 2020

Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in intensive care units in US hospitals, 1992-2003.

1 reference

12 December 2020

Phase 2 study of ceftaroline versus standard therapy in treatment of complicated skin and skin structure infections

1 reference

12 December 2020

Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists

1 reference

12 December 2020

Vancomycin-resistant Staphylococcus aureus in the United States, 2002-2006.

1 reference

12 December 2020

In vivo efficacy of ceftaroline (PPI-0903), a new broad-spectrum cephalosporin, compared with linezolid and vancomycin against methicillin-resistant and vancomycin-intermediate Staphylococcus aureus in a rabbit endocarditis model

1 reference

12 December 2020

Evaluation of PPI-0903M (T91825), a novel cephalosporin: bactericidal activity, effects of modifying in vitro testing parameters and optimization of disc diffusion tests.

1 reference

12 December 2020

In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States

1 reference

12 December 2020

Pharmacodynamics of a new cephalosporin, PPI-0903 (TAK-599), active against methicillin-resistant Staphylococcus aureus in murine thigh and lung infection models: identification of an in vivo pharmacokinetic-pharmacodynamic target

1 reference

12 December 2020

Emerging cephalosporins

1 reference

12 December 2020

In vitro evaluation of the antimicrobial activity of ceftaroline against cephalosporin-resistant isolates of Streptococcus pneumoniae

1 reference

12 December 2020

Hematologic effects of linezolid: summary of clinical experience

1 reference

12 December 2020

Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men.

1 reference

12 December 2020

In vitro antimicrobial activity of a new cephalosporin, ceftaroline, and determination of quality control ranges for MIC testing

1 reference

12 December 2020

In vitro antimicrobial activity of T-91825, a novel anti-MRSA cephalosporin, and in vivo anti-MRSA activity of its prodrug, TAK-599.

1 reference

12 December 2020

In vitro activity of ceftaroline against Streptococcus pneumoniae isolates exhibiting resistance to penicillin, amoxicillin, and cefotaxime.

1 reference

12 December 2020

Surveillance for methicillin-resistant Staphylococcus aureus in Canadian hospitals--a report update from the Canadian Nosocomial Infection Surveillance Program

1 reference

12 December 2020

Methicillin-resistant Staphylococcus aureus in Europe, 1999-2002

1 reference

12 December 2020

Ceftaroline fosamil, a cephalosporin derivative for the potential treatment of MRSA infection.

1 reference

12 December 2020

Investigational treatments for postoperative surgical site infections

1 reference

12 December 2020

The bacterial envelope as a target for novel anti-MRSA antibiotics

1 reference

12 December 2020

Antimicrobial activities of Ceftaroline and ME1036 tested against clinical strains of community-acquired methicillin-resistant Staphylococcus aureus

1 reference

12 December 2020

Antimicrobial resistance in Canada.

1 reference

12 December 2020

Co-opting the cell wall in fighting methicillin-resistant Staphylococcus aureus: potent inhibition of PBP 2a by two anti-MRSA beta-lactam antibiotics

1 reference

12 December 2020

Synthetic peptidoglycan substrates for penicillin-binding protein 5 of Gram-negative bacteria

1 reference

12 December 2020

Antimicrobial activity and spectrum of PPI-0903M (T-91825), a novel cephalosporin, tested against a worldwide collection of clinical strains

1 reference

12 December 2020

Tigecycline: a novel glycylcycline antibiotic

1 reference

12 December 2020

Antimicrobial pharmacodynamics: critical interactions of 'bug and drug'.

1 reference

12 December 2020